Organization & Developments: ConforMIS

Parents

2018: Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR
2021: Conformis: Emerging Surgical Implant Developer
Built and brought to market the only full line of patient-specific implants and instruments for the treatment of knee osteoarthritis, ConforMIS
Its proprietary intellectual property includes more than 300 patents and patent applications in the areas of imaging software, image processing, implant design, surgical techniques, instrumentation, and manufacturing, spanning knee, hip, shoulder, spine, a
The company, which more than doubled its revenues in 2011